Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,199 | -20,279 | -12,069 | N/A | -13,990 |
| Depreciation Amortization | 772 | 373 | 204 | N/A | 302 |
| Accounts payable and accrued liabilities | 5,258 | 371 | 573 | N/A | N/A |
| Other Working Capital | 3,004 | 1,098 | 386 | N/A | -1,178 |
| Other Operating Activity | -1,087 | 1,544 | 637 | 0 | 724 |
| Operating Cash Flow | $-25,252 | $-16,893 | $-10,269 | $N/A | $-14,142 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,847 | -5,867 | -1,332 | N/A | -942 |
| Investing Cash Flow | $-11,847 | $-5,867 | $-1,332 | $N/A | $-942 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 113,704 | -196 | -196 | 0 | 93,622 |
| Financing Cash Flow | $113,704 | $-196 | $-196 | $N/A | $93,622 |
| Exchange Rate Effect | 3,650 | -3,035 | -6,323 | N/A | 8,373 |
| Beginning Cash Position | 97,594 | 97,594 | 97,594 | N/A | 10,683 |
| End Cash Position | 177,849 | 71,603 | 79,474 | N/A | 97,594 |
| Net Cash Flow | $80,255 | $-25,991 | $-18,120 | $N/A | $86,911 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,252 | -16,893 | -10,269 | N/A | -14,142 |
| Capital Expenditure | -11,847 | -5,867 | -1,332 | N/A | N/A |
| Free Cash Flow | -37,099 | -22,760 | -11,601 | 0 | -14,142 |